ImmunityBio, Inc. - IBRX

SEC FilingsOur IBRX Tweets

About Gravity Analytica

Recent News

  • 12.02.2025 - December 2, 2025 - December 4, 2025 : Piper Sandler 37th Annual Healthcare Conference
  • 12.02.2025 - December 2, 2025 - December 4, 2025 : Piper Sandler 37th Annual Healthcare Conference
  • 11.06.2025 - November 6, 2025 - November 8, 2025 : LUGPA 2025 Annual Meeting
  • 11.06.2025 - November 6, 2025 - November 8, 2025 : LUGPA 2025 Annual Meeting
  • 11.03.2025 - November 3, 2025 - November 5, 2025 : BIO-Europe
  • 11.03.2025 - November 3, 2025 - November 5, 2025 : BIO-Europe
  • 09.08.2025 - ImmunityBio’s ANKTIVA® Reverses Lymphopenia and Extends Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Resistant to Checkpoint Therapy
  • 09.08.2025 - ImmunityBio’s ANKTIVA® Reverses Lymphopenia and Extends Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Resistant to Checkpoint Therapy
  • 09.08.2025 - ImmunityBio’s ANKTIVA® Reverses Lymphopenia and Extends Overall Survival in Patients With Advanced Non-Small Cell Lung Cancer Resistant to Checkpoint Therapy
  • 09.08.2025 - September 8, 2025 - September 10, 2025 : H.C. Wainwright 27th Annual Global Investment Conference

Recent Filings